Completed Genetics & Molecular Biology Cells, Biochemistry & Physiology

Centre for Developmental and Biomedical Genetics

In plain English

AI plain-English summary

A tropical fish, a fruit fly, or a tiny worm can now stand in for a human patient in the hunt for new drugs. The Centre for Developmental and Biomedical Genetics uses these simple animals to model human diseases that cannot be recreated in a petri dish—conditions like clogged arteries, inflamed tissues, or failing neurons. Over the past two decades, scientists have discovered that these organisms share many of the same genes and cellular machinery as humans. By tweaking the animal versions of genes linked to human illness, researchers can create living models of cardiovascular, inflammatory, and neurodegenerative diseases. They can then test potential therapies on these models or search for new genes that drive the pathology. This is fundamental science: it aims to uncover the molecular roots of disease rather than deliver an immediate treatment. But the payoff is concrete—new leads for diagnosis, management, and eventual cures. Similar work with model organisms has already transformed cancer therapy and developmental biology. Here, the goal is to expand that knowledge into areas where whole-body interactions matter most.

View original technical description
Many human diseases involve interactions between various cell types, tissues and organ systems that cannot readily be reproduced in the tissue culture dish. The main goal of the Centre for Developmental and Biomedical Genetics is to use non-mammalian species to model human disease processes in a whole organism context. Our approach is based on discoveries made in the past two decades that have revealed that organisms as simple as a tropical fish, fruit fly or even a worm share many cellular functions and have many genes in common with humans. By manipulating these organisms’ versions of human disease associated genes, we can establish models for a variety of debilitating diseases and exploit these to discover new therapeutic agents. In addition, we can generate pathological conditions – such as the blockage of arteries – in these simple organisms and use these to discover novel genes that underlie the corresponding human pathology. Through these approaches we aim to expand our knowledge of the molecular basis of a range of human diseases, including cardiovascular, inflammatory and neurodegenerative, giving new insights into their causes and providing new leads for their diagnosis, management and cure.

View the original record at the funder ↗

Researchers

Marysia Placzek (Principal Investigator)Philip Ingham (Principal Investigator)R Boucher (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

MRC Centre for Neuropsychiatric Genetics and Genomics
Congenital Anomalies - Patient-led Functional Genomics
Accelerated Discovery of Molecules and Biological Pathways Perturbed in Mendelian Neurological Diseases
Congenital Anomalies: Patient-led Functional Genomics
MRC Centre for Neurodevelopmental Disorders

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.